secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001193125-24-105862
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received Nasdaq letter on April 19, 2024, for bid price closing below $1.00 for 30 consecutive business days.
- Has until October 16, 2024 (180 days) to regain compliance; stock must close at $1.00+ for 10 consecutive days.
- May consider reverse stock split to cure deficiency; no assurance of regaining compliance.
- Stock continues trading under MCRB on Nasdaq Global Select Market during cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524105862/0001193125-24-105862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524105862/d804228d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-105862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer